Stifel Nicolaus Issues Positive Forecast for Travere Therapeutics (NASDAQ:TVTX) Stock Price
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target increased by Stifel Nicolaus from $22.00 to $23.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a hold rating on the stock. A number of other research firms have also recently issued reports on TVTX. Guggenheim reissued a “buy” rating and […]
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target increased by Stifel Nicolaus from $22.00 to $23.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a hold rating on the stock. A number of other research firms have also recently issued reports on TVTX. Guggenheim reissued a “buy” rating and […]
